Tuesday, 15 October 2019

Biocon Biologics receive EU GMP Certification

14 June 2019 | News

This was a surveillance inspection of existing DP and OS facilities and a pre-approval inspection of additional DP manufacturing line

Biocon has received the Certificate of GMP compliance from EMA for its Biologics Drug Product (DP) as well as Drug Substance (DS) facilities at Biocon Park, Bengaluru.

These facilities, used for the manufacture of Biocon's portfolio of biosimilars, were inspected by the European agency in March 2019.

“This was a surveillance inspection of our existing DP and OS facilities and a pre-approval inspection of our additional DP manufacturing line.” said the company spokesperson.

The spokesperson stated further, “This certification will enable us to continue addressing the growing needs of patients in the EU markets and enhance access to our high quality biosimilars. We remain committed to global standards of quality and compliance."

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Is Asia-Pacific dominating the global digital transformation in healthcare market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls